---
title: "ADC Therapeutics in Lausanne, Switzerland (NYSE: ADCT), leader in antibody drug conjugates, amended a royalty financing agreement on Feb. 23, 2026."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276600374.md"
description: "ADC Therapeutics SA (NYSE: ADCT) announced an amendment to its royalty financing agreement on February 23, 2026, in Lausanne, Switzerland. This update is a significant development for the company, reinforcing its leadership in antibody drug conjugates (ADCs). While specific details of the amendment were not disclosed, the announcement underscores the company's commitment to expanding its influence in the pharmaceutical industry."
datetime: "2026-02-23T12:19:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276600374.md)
  - [en](https://longbridge.com/en/news/276600374.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276600374.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/276600374.md) | [繁體中文](https://longbridge.com/zh-HK/news/276600374.md)


# ADC Therapeutics in Lausanne, Switzerland (NYSE: ADCT), leader in antibody drug conjugates, amended a royalty financing agreement on Feb. 23, 2026.

In Lausanne, Switzerland on February 23, 2026, ADC Therapeutics SA (NYSE: ADCT), a prominent company specializing in antibody drug conjugates (ADCs), revealed an update to its royalty purchase agreement. This amendment signifies a significant development for the company as it solidifies its position as a global leader in the field. The specific details of the amendment, including the entities involved and the revised terms, were not disclosed in the announcement. This news highlights the company's ongoing efforts to expand its presence and influence in the pharmaceutical industry.

### Related Stocks

- [ADC Therapeutics SA (ADCT.US)](https://longbridge.com/en/quote/ADCT.US.md)

## Related News & Research

- [ADC Therapeutics Announces New Employee Inducement Grant | ADCT Stock News](https://longbridge.com/en/news/281417749.md)
- [ADC Therapeutics (ADCT) to Release Earnings on Tuesday](https://longbridge.com/en/news/277966267.md)
- [ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5%  - Here's Why](https://longbridge.com/en/news/275092526.md)
- [ADC Therapeutics SA Updates Corporate Strategy and Financial Outlook](https://longbridge.com/en/news/272279996.md)
- [ADC Therapeutics Announces Preliminary 2025 Financial Results and Outlook](https://longbridge.com/en/news/271993547.md)